Clinical Trial Update: Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating intratumoral injections of INXN-3001 in patients with stage III or IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• INXN-3001

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Melanoma | Phase 1 | Status: COMPLETED